Each year, it is estimated that over 57,000 women are diagnosed with invasive cervical cancer. Although preventable through vaccination and appropriate screening, one in four women and people with a cervix do not attend cervical screening. As leaders within the medical industry, we must continue to educate our communities and change this notion. During Cervical Health Awareness Month, we at iData want to highlight issues related to cervical cancer, HPV disease, and the importance of early detection. Colposcopy procedures are an integral aspect of cervical cancer and HPV detection, and the overall market has been seeing substantial growth since its inception. Within this blog post, iData aims to provide education on what colposcopy is and the market drivers associated with this procedure.
What is a Colposcope? What is it Used For?
A colposcope is a large, electric microscope with a source of light attached to the end. The view on the colposcope can be magnified and is used to visually examine the cervix, vaginal wall and vulva during a colposcopy. A colposcopy is performed to more accurately detect premalignant and malignant lesions, which is often a procedure that follows a Pap smear when abnormalities are noticed. Results from the colposcopy procedure can show evidence of dysplasia, cancer, HPV, and more. The efficiency of colposcopy is often appreciated as the procedure is completed at a hospital or clinic and the patient can leave as soon as the procedure is complete.
3 Global Trends in The Colposcope Market:
- The Emergence of Video Colposcopy
- Prevalence of Cervical Cancer
- Increase in Physicians Performing Colposcopy
The Emergence of Video Colposcopy
Market growth within the global colposcopy market will be largely attributed to technological innovations, such as video solutions that are prompting ASP increases due to higher price points. As the market shifts towards vide colposcopes versus non-video colposcopes, the ASP will continue to increase.
Prevalence of Cervical Cancer
Colposcopy procedures are often used to screen for cancer. Globally, approximately 570,000 women are diagnosed with cervical cancer, and 310,000 of those die from this illness each year. As the method of HPV testing gains acceptance over traditional cytology methods, the number of women referred to for colposcopy following cervical cancer screening is set to increase. Therefore, referrals for colposcopy are rapidly increasing, driving the market towards further growth.
Increase in Physicians Performing Colposcopy
An increased number of physicians of other specialties are becoming competent with gynecological examinations, therefore resulting in an increase of screenings which help drive the market. Family doctors are starting to purchase colposcopes and their associated devices, which in turn further drives the market.
MARKET RECAP AND FURTHER INSIGHTS
Overall, the global colposcope market was valued at $60.3 million in 2020 and is expected to increase over the forecast period at a CAGR of 13.1% to reach $143.1 million by 2027. Those with a cervix are told they have cervical cell changes after each yearly screening, and many more are given an HPV diagnosis. This can mean more tests, treatments, and can often result in an incredibly challenging time. As medical professionals, we want to ensure we all have the most up-to-date information to support our patients when they need it most. For more information on the Global Colposcopy Market, including unit sales, average selling prices, market drivers and limiters, competitive market share analysis, and more, follow the link below to receive a free research summary of this report. In addition, we offer our complete Global Gynecology Devices report series which includes the analysis of the cardiac surgery market in 70 countries and 7 regions.